CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Clairélaine Ouellet-Plamondon

OPENALEX: A5008221418↗ORCID: 0000-0001-7450-4496↗

Affiliations

Organizations

Centre Hospitalier de l’Université de Montréalauthorship · CA Hôpital Notre-Dameauthorship · CA Université de Montréalauthorship · CA

Public evidence

2 connected articles

Correlates of Engagement and Associations with Outcomes in a Cannabis Harm Reduction Mobile App for Youth with First-Episode Psychosis: Exploratory Findings from the CHAMPS Pilot Randomized Controlled Trial.2026 · PubMed Central Open Access Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale.2024 · Europe PMC

Registered research

Connected studies

A Randomized Pilot Trial of a Cannabis Harm Reduction e-Intervention (CHAMPS) for Young Adults With Early Psychosis Who Use Cannabisnct04968275

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Clairélaine Ouellet-Plamondon - Medical Cannabis Research Engine